Health Care Equipment

Asensus Surgical

The merger between Asensus Surgical and... has been completed

Asensus Surgical, Inc. to release second quarter financial and operational results

Asensus Surgical, Inc. Postpones Shareholder Special Meeting

Asensus Surgical receives Glass, Lewis & Co.'s recommendation to support merger with KARL STORZ Endoscopy-America

Asensus Surgical Announces FDA Approval

Asensus Surgical Installs First Senhance Surgical System at Rocky Mountain Children's Hospital

Asensus Surgical Receives FDA 510(k) Clearance for Senhance Surgical System

Ademi LLP is investigating Asensus Surgical

Asensus Surgical reaches merger agreement with KARL STORZ Endoscopy-America

OPTIMI HEALTH CORP

HCW Biologics

GCL Global

Silexion Therapeutics

Micware

BiomX

MetaVia

Vida Global

MicroAlgo

Tradr 2X Long XNDU Daily ETF

The Ostomy Dressing Market is projected to grow from USD 3.80 billion in 2026 to USD 4.73 billion by 2031, at a CAGR of 4.4%. The growth is driven by increasing colorectal cancer cases, an aging population, and innovations in product technology. The largest market share in 2025 is expected from ostomy bags/pouches, particularly colostomy bags, due to high prevalence rates of colorectal cancer. Europe is anticipated to hold the largest market share, followed by North America.

prnewswire

10:01 ETOstomy Dressing Market worth $4.73 billion by 2031 | MarketsandMarkets™

STAA

ASXC

SBIO

Reach Surgical, a division of Genesis MedTech, has received CE Mark approval for its iREACH IRIS, the first powered reusable stapler featuring Real-Time Firing Curve™ and 90° articulation. This innovative device provides surgeons with real-time insights into tissue behavior during procedures, enhancing surgical judgment and reducing complications like anastomotic leaks. The iREACH IRIS is designed for single-patient use, streamlining workflow and minimizing cross-contamination risks. It aims to improve surgical outcomes in various procedures, including colorectal and thoracic surgeries, by offering better access and precision control.

STAAR Surgical

AJJ Medtech

Vicarious Surgical

Sanara Medtech

Proshares Ultra Nasdaq Biotech

SPDR S&P Biotech

VanEck Biotech ETF

SPDR S&P Health Equip

iShares US Medical Devices

Direxion S&P Biotech Bull 3X

ALPS Medical Breakthrough

First Trust NYSE Arca Biotech Index Fd

Invesco Biotechnology & Genome ETF

iShares Biotechnology ETF

23:30 ETReach Surgical Receives CE Mark Approval for iREACH IRIS, First Powered Reusable Stapler with Real-Time Firing Curve™ and 90° Articulation

ISUL

ISRG

In New Delhi on March 20, 2026, a recent market report from MarkNtel Advisors revealed that the North America Robotics Assisted Surgery (RAS) System Market is anticipated to experience a growth rate of approximately 6.04% between 2026 and 2032. This growth is primarily attributed to factors such as the increasing demand for...

Unusual Whales

Zimmer Biomet

Medtronic

Stryker

GraniteShares 2x Long ISRG Daily ETF

Health Care Select Sector SPDR

Intuitive Surgical

VG Health

Smith and Nephew

iShares Global Healthcare

Johnson & Johnson

North America Robotics Assisted Surgery (RAS) System Market Forecast to Reach USD 4.28 Billion by 2032, Reports MarkNtel Advisors

UTRS

Dakota Wealth Management reduced its stake in Intuitive Surgical, Inc. (NASDAQ: ISRG) by 63.9% in Q3, now holding 4,692 shares valued at $2.1 million. Other institutional investors, including Norges Bank and Vanguard Group, have also adjusted their positions. Intuitive Surgical's stock rose 2.5%, opening at $506.17, with a market cap of $179.76 billion. The company reported earnings of $2.53 per share, exceeding estimates, and revenue increased by 18.8% year-over-year. Analysts maintain a consensus rating of "Moderate Buy" with an average price target of $615.86.

Market Beat

Minerva Surgical

Dakota Wealth Management Lowers Stock Position in Intuitive Surgical, Inc. $ISRG

Acusensus Ltd reported a 40% increase in half-year revenue to $40.3 million, driven by new contracts and growth in the U.S. market. However, the company faced a net loss of $20.8 million due to high operating costs and a $16 million legal settlement. Despite the loss, net tangible assets per share rose to $0.33, and no dividend was declared. Analysts rate the stock as a Buy with a price target of A$2.30, reflecting confidence in the company's growth strategy despite near-term margin pressures.

Tip Ranks

Acusensus grows revenue 40% but swings to deeper half-year loss on legal settlement

What Are Wall Street Analysts' Target Price for Intuitive Surgical Stock?

Barchart Option

What Are Wall Street Analysts' Target Price for Intuitive Surgical Stock?

Compass Surgical Partners has partnered with local physicians to launch the Cardiovascular Surgical Institute of Northwest Florida, the first outpatient catheterization lab in the region. Located in Panama City, the facility offers interventional cardiology, electrophysiology, and vascular surgery procedures. It features two catheterization labs and aims to provide high-quality, affordable care closer to home. The center plans to seek accreditation from the Accreditation Commission for Health Care (ACHC). This initiative is part of a growing trend in the ASC sector to enhance cardiovascular care accessibility.

08:43 ET
			
			
				COMPASS SURGICAL PARTNERS AND CARDIOVASCULAR INSTITUTE OF NORTHWEST FLORIDA BRING FIRST OUTPATIENT CATH LAB TO REGION

Asensus Surgical(ASXC.US)

10:01 ETOstomy Dressing Market worth $4.73 billion by 2031 | MarketsandMarkets™

23:30 ETReach Surgical Receives CE Mark Approval for iREACH IRIS, First Powered Reusable Stapler with Real-Time Firing Curve™ and 90° Articulation

North America Robotics Assisted Surgery (RAS) System Market Forecast to Reach USD 4.28 Billion by 2032, Reports MarkNtel Advisors

Dakota Wealth Management Lowers Stock Position in Intuitive Surgical, Inc. $ISRG

Acusensus grows revenue 40% but swings to deeper half-year loss on legal settlement

What Are Wall Street Analysts' Target Price for Intuitive Surgical Stock?

08:43 ET COMPASS SURGICAL PARTNERS AND CARDIOVASCULAR INSTITUTE OF NORTHWEST FLORIDA BRING FIRST OUTPATIENT CATH LAB TO REGION